During the past decade, Pediatric Brain Tumor Consortium conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Pediatric Brain Tumor Consortium" #1 collaborator was "National Cancer Institute (NCI)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Pediatric Brain Tumor Consortium" are "Recurrent Childhood Ependymoma" (8 trials), "Recurrent Childhood Medulloblastoma" (8 trials), "Childhood Oligodendroglioma" (6 trials), "Recurrent Childhood Brain Stem Glioma" (6 trials) and "Childhood Central Nervous System Germ Cell Tumor" (5 trials). Many other conditions were trialed in "Pediatric Brain Tumor Consortium" in a lesser frequency.

Most popular intervention types in "Pediatric Brain Tumor Consortium" are "Drug" (14 trials), "Other" (11 trials), "Radiation" (5 trials), "Procedure" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "laboratory biomarker analysis" (7 trials), "pharmacological study" (5 trials), "Laboratory Biomarker Analysis" (3 trials), "Pharmacological Study" (3 trials) and "3-Dimensional Conformal Radiation Therapy" (2 trials). Other intervention names were less common.

The vast majority of trials in "Pediatric Brain Tumor Consortium" are 14 trials for "All" genders.

Currently, there are NaN active trials in "Pediatric Brain Tumor Consortium". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Pediatric Brain Tumor Consortium, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Pediatric Brain Tumor Consortium, 12 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".